skip to main content

Lipid therapy pregnancy — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiovascular TherapeuticsLipid therapy pregnancyGPhC CRA

A 32-year-old patient taking atorvastatin 20 mg daily tells the pharmacist they have just had a positive pregnancy test. The statin was started for primary prevention after a previous high QRISK discussion. What is the most appropriate alternative?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Advise stopping atorvastatin and contacting the prescriber promptly

Statins should be stopped during pregnancy because lipid-lowering treatment for primary prevention is not appropriate in this context. The patient should contact their prescriber for review and reassurance about next steps. Switching between statins does not solve the pregnancy issue. Adding ezetimibe would not be appropriate without specialist review.

Reference: BNF